Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» EOS-448
EOS-448
GSK pays iTeos $625M upfront to join Merck, Roche and the rest in TIGIT immuno-oncology race
Fierce Biotech
Mon, 06/14/21 - 10:17 am
GSK
iTeos Therapeutics
EOS-448
immuno-oncology
iTeos busts out early human data for anti-TIGIT antibody. Is it enough to match up with Roche, Merck?
Endpoints
Sun, 04/11/21 - 11:48 pm
anti-TIGIT
iTeos Therapeutics
EOS-448